Lyumjev
Payments companies reported to CMS as associated with Lyumjev. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lyumjev, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lyumjev
These are the largest totals companies reported as associated with Lyumjev. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Pablo Mora | Dallas, TX | Endocrinology, Diabetes & Metabolism | $24,995.65 |
| Bruce Bode | Atlanta, GA | Endocrinology, Diabetes & Metabolism | $22,157.85 |
| John Gilbert | Fullerton, CA | Endocrinology, Diabetes & Metabolism | $17,055.51 |
| Brian Lake | Largo, FL | Endocrinology, Diabetes & Metabolism | $16,505.79 |
| Gnanagurdasan Prakasam | Sacramento, CA | Pediatric Endocrinology | $16,225.00 |
| Mark Warren | Greenville, NC | Endocrinology, Diabetes & Metabolism | $11,086.14 |
| Mark Corriere | Columbia, MD | Internal Medicine | $9,450.00 |
| Christian Gastelum | Los Angeles, CA | Endocrinology, Diabetes & Metabolism | $8,761.77 |
| Serge Jabbour | Philadelphia, PA | Endocrinology, Diabetes & Metabolism | $7,500.00 |
| William Litchfield | Henderson, NV | Endocrinology, Diabetes & Metabolism | $7,243.93 |
Prescribed Lyumjev?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.